2 listed companies, Silva Pharmaceuticals & Ambee Pharmaceuticals Limited disclose their financial reports for the third quarter, (January – March 24). This information is known from DSE Sources.
Silva Pharmaceuticals: The company’s earnings per share (EPS) was Tk 0.04 paisa in Q3 of the current financial year (January – March 24). EPS was Tk 0.06 paisa during the same period last year. NAV per share was Tk. 16.92 on March 31, 2024.
Ambee Pharmaceuticals: The company’s earnings per share (EPS) was Tk 0.80 paisa in Q3 of the current financial year (January – March 24). EPS was loss Tk 0.70 paisa during the same period last year. NAV per share was Tk. 10.23 on March 31, 2024.
Share this
